Latest Post

December 23, 2020

Container Closure Integrity Evaluation for Cell and Gene Therapies

With the growth of gene and cell therapies, there is an increased need to characterize container closure systems (CCS) at the low temperatures experienced during their lifecycles: ultra-low (-80°C) for genes and cryogenic (-180°C) for cells. West’s Integrated Solutions platform includes the state-of-the-art container closure integrity (CCI) capabilities needed for these therapies.
Olga Laskina

Olga Laskina, PhD.

Sr. Technical Account Specialist, TCS NA

Previous Posts
examples of bad crimps

July 13, 2020

Consistent Crimp, Consistent CCI

Gabrielle Gehron

Gabrielle Gehron

Associate Technical Account Specialist, TCS

Dynamic Sealing Container Closure Testing

March 23, 2020

Dynamic Sealing Performance of Container Closure Systems at Low Temperature

Qingyu Zeng

Qingyu Zeng Ph.D.

Fellow Scientist and Technical Director, Scientific Insights Lab

Capped Vials

December 09, 2019

Evaluation of Container Systems with Residual Seal Force (RSF)

Mary Tan

Mary Tan

Specialist, Scientific Affairs, Singapore, Jurong

Load more